Form D · Private Equity Fund
N2C Derm & Pain LP
New York, NY · CIK 0001771266
Offering snapshot reported Apr 4, 2019 · SEC filing
- Reported sold
- $42.1M Indefinite offering
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 26, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 4, 2019 | Initial | $42,100,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-336417
Source: Form D, filed Apr 4, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jordan Bradley | Executive |
| Clay Cole | Executive |
| Tjarko Hektor | Executive |
| Dan Townsend | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
747 3 Rd Avenue, Suite 2101
New York, NY, 10017
New York, NY, 10017